|
|
.
See Category: Diseases of the respiratory system
See Header: Other specified disorders of nose and nasal sinuses
ICD-10 (CM) Code and Descriptor
|
J34.89 |
Other specified disorders of nose and nasal sinuses
|
J3489 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 24.48%
|
25.43%
|
18.53%
|
11.24%
|
6.52%
|
4.10%
|
2.65%
|
1.77%
|
1.29%
|
0.98%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for J34.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
12,911
|
12,928
|
|
70486
|
CT MAXILLOFACIAL W/O DYE |
5,780
|
5,780
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
3,728
|
3,728
|
|
31231
|
NASAL ENDOSCOPY DX |
3,423
|
3,423
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
2,830
|
2,830
|
|
U0005
|
INFEC AGEN DETEC AMPLI PROBE |
2,423
|
2,424
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,980
|
1,990
|
|
G1004
|
CDSM NDSC |
1,762
|
1,840
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,631
|
2,731
|
|
G0467
|
FQHC VISIT, ESTAB PT |
1,627
|
1,627
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,586
|
54,625
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,573
|
6,717
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,570
|
12,440
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
1,497
|
1,497
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,490
|
1,887
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,425
|
1,425
|
|
87070
|
CULTURE OTHR SPECIMN AEROBIC |
1,421
|
1,435
|
|
C9803
|
HOPD COVID-19 SPEC COLLECT |
1,211
|
1,223
|
|
31237
|
NSL/SINS NDSC SURG BX POLYPC |
1,205
|
1,205
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,089
|
2,760
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
J34.89 related to the following DRG Codes:
154-156
795
|
